Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654
Clinical trial NCT06389955 · COMPLETED
Trial details
- NCT number
- NCT06389955
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-22
- Primary completion
- 2023-08-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.